News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

University of Washington, University of Texas Medical School Branch and Kineta Inc. Granted $8.1 Million for Biodefense Antiviral Drug Development



5/8/2012 9:58:18 AM

SEATTLE--(BUSINESS WIRE)--In collaboration with the University of Washington and the University of Texas Medical Branch at Galveston, Seattle-based biotech company, Kineta, Inc. announced a new $8.1 million biodefense grant to develop new drugs to treat some of the world’s most dangerous diseases, including Ebola, plague, Japanese encephalitis, and other lethal pathogens.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES